203 related articles for article (PubMed ID: 33094859)
21. Blood RNA biomarker panel detects both left- and right-sided colorectal neoplasms: a case-control study.
Chao S; Ying J; Liew G; Marshall W; Liew CC; Burakoff R
J Exp Clin Cancer Res; 2013 Jul; 32(1):44. PubMed ID: 23876008
[TBL] [Abstract][Full Text] [Related]
22. Genome-wide analysis of long non-coding RNA expression and function in colorectal cancer.
Jing F; Jin H; Mao Y; Li Y; Ding Y; Fan C; Chen K
Tumour Biol; 2017 May; 39(5):1010428317703650. PubMed ID: 28468580
[TBL] [Abstract][Full Text] [Related]
23. Early detection of colorectal cancer based on presence of methylated syndecan-2 (SDC2) in stool DNA.
Han YD; Oh TJ; Chung TH; Jang HW; Kim YN; An S; Kim NK
Clin Epigenetics; 2019 Mar; 11(1):51. PubMed ID: 30876480
[TBL] [Abstract][Full Text] [Related]
24. To Wnt or Lose: The Missing Non-Coding Linc in Colorectal Cancer.
Shen P; Pichler M; Chen M; Calin GA; Ling H
Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28930145
[TBL] [Abstract][Full Text] [Related]
25. Non-coding RNAs as Biomarkers for Colorectal Cancer Screening and Early Detection.
Slaby O
Adv Exp Med Biol; 2016; 937():153-70. PubMed ID: 27573899
[TBL] [Abstract][Full Text] [Related]
26. Investigation of MicroRNA-21 Expression Levels in Serum and Stool as a Potential Non-Invasive Biomarker for Diagnosis of Colorectal Cancer.
Bastaminejad S; Taherikalani M; Ghanbari R; Akbari A; Shabab N; Saidijam M
Iran Biomed J; 2017 Mar; 21(2):106-13. PubMed ID: 27432735
[TBL] [Abstract][Full Text] [Related]
27. Identification of stool miR-135b-5p as a non-invasive diaognostic biomarker in later tumor stage of colorectal cancer.
Li L; Wang A; Cai M; Tong M; Chen F; Huang L
Life Sci; 2020 Nov; 260():118417. PubMed ID: 32931801
[TBL] [Abstract][Full Text] [Related]
28. LncRNA MEG3 acts a biomarker and regulates cell functions by targeting ADAR1 in colorectal cancer.
Wang W; Xie Y; Chen F; Liu X; Zhong LL; Wang HQ; Li QC
World J Gastroenterol; 2019 Aug; 25(29):3972-3984. PubMed ID: 31413531
[TBL] [Abstract][Full Text] [Related]
29. Circulating long non-coding RNA colon cancer-associated transcript 2 protected by exosome as a potential biomarker for colorectal cancer.
Wang L; Duan W; Yan S; Xie Y; Wang C
Biomed Pharmacother; 2019 May; 113():108758. PubMed ID: 30877883
[TBL] [Abstract][Full Text] [Related]
30. Circulating LncRNAs landscape as potential biomarkers in breast cancer.
Pourramezan Z; Attar FA; Yusefpour M; Azizi M; Oloomi M
Cancer Rep (Hoboken); 2023 Feb; 6(2):e1722. PubMed ID: 36274054
[TBL] [Abstract][Full Text] [Related]
31. microRNA-221 and microRNA-18a identification in stool as potential biomarkers for the non-invasive diagnosis of colorectal carcinoma.
Yau TO; Wu CW; Dong Y; Tang CM; Ng SS; Chan FK; Sung JJ; Yu J
Br J Cancer; 2014 Oct; 111(9):1765-71. PubMed ID: 25233396
[TBL] [Abstract][Full Text] [Related]
32. Identification of a serum circulating lncRNA panel for the diagnosis and recurrence prediction of bladder cancer.
Duan W; Du L; Jiang X; Wang R; Yan S; Xie Y; Yan K; Wang Q; Wang L; Zhang X; Pan H; Yang Y; Wang C
Oncotarget; 2016 Nov; 7(48):78850-78858. PubMed ID: 27793008
[TBL] [Abstract][Full Text] [Related]
33. Long non-coding RNAs LOC285194, RP11-462C24.1 and Nbla12061 in serum provide a new approach for distinguishing patients with colorectal cancer from healthy controls.
Wang C; Yu J; Han Y; Li L; Li J; Li T; Qi P
Oncotarget; 2016 Oct; 7(43):70769-70778. PubMed ID: 27683121
[TBL] [Abstract][Full Text] [Related]
34. Identification of an exosomal long non-coding RNAs panel for predicting recurrence risk in patients with colorectal cancer.
Zhang Y; Liu H; Liu X; Guo Y; Wang Y; Dai Y; Zhuo J; Wu B; Wang H; Zhang X
Aging (Albany NY); 2020 Apr; 12(7):6067-6088. PubMed ID: 32246818
[TBL] [Abstract][Full Text] [Related]
35. Identification and development of long non-coding RNA-associated regulatory network in colorectal cancer.
Pan H; Pan J; Song S; Ji L; Lv H; Yang Z
J Cell Mol Med; 2019 Aug; 23(8):5200-5210. PubMed ID: 31144439
[TBL] [Abstract][Full Text] [Related]
36. LncRNAs in colorectal cancer: Biomarkers to therapeutic targets.
Chen LJ; Chen X; Niu XH; Peng XF
Clin Chim Acta; 2023 Mar; 543():117305. PubMed ID: 36966964
[TBL] [Abstract][Full Text] [Related]
37. Low level of exosomal long non-coding RNA
Oehme F; Krahl S; Gyorffy B; Muessle B; Rao V; Greif H; Ziegler N; Lin K; Thepkaysone ML; Polster H; Tonn T; Schneider M; Weitz J; Baenke F; Kahlert C
RNA Biol; 2019 Oct; 16(10):1339-1345. PubMed ID: 31251124
[TBL] [Abstract][Full Text] [Related]
38. Diagnostic microRNA markers to screen for sporadic human colon cancer in stool: I. Proof of principle.
Ahmed FE; Ahmed NC; Vos PW; Bonnerup C; Atkins JN; Casey M; Nuovo GJ; Naziri W; Wiley JE; Mota H; Allison RR
Cancer Genomics Proteomics; 2013; 10(3):93-113. PubMed ID: 23741026
[TBL] [Abstract][Full Text] [Related]
39. LncRNAs: Potential Novel Prognostic and Diagnostic Biomarkers in Colorectal Cancer.
Dastmalchi N; Safaralizadeh R; Nargesi MM
Curr Med Chem; 2020; 27(30):5067-5077. PubMed ID: 30827228
[TBL] [Abstract][Full Text] [Related]
40. Use of integrin alpha 6 transcripts in a stool mRNA assay for the detection of colorectal cancers at curable stages.
Beaulieu JF; Herring E; Kanaoka S; Tremblay É
Oncotarget; 2016 Mar; 7(12):14684-92. PubMed ID: 26895101
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
